Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of FLT3 monoclonal antibody, clone BV10A4
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | IP,IHC-Fr,Flow Cyt |
More info about FLT3 monoclonal antibody, clone BV10A4
| Brand: | Abnova |
| Reference: | MAB8212 |
| Product name: | FLT3 monoclonal antibody, clone BV10A4 |
| Product description: | Mouse monoclonal antibody raised against native FLT3. |
| Clone: | BV10A4 |
| Isotype: | IgG1 |
| Gene id: | 2322 |
| Gene name: | FLT3 |
| Gene alias: | CD135|FLK2|STK1 |
| Gene description: | fms-related tyrosine kinase 3 |
| Immunogen: | Native purified FLT3 from BV-173 leukemic cell line. |
| Form: | Liquid |
| Concentration: | 1 mg/mL |
| Recommend dilutions: | Flow Cytometry (10 ug/mL per 106 cells/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody reacts with FLT3, a 130-160 KDa type III receptor tyrosine kinase that is involved in early steps ofhematopoiesis. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Flow cytometric analysis of FLT3 in K-562 cells with 5 ug/mL of FLT3 monoclonal antibody, clone BV10A4 (Cat # MAB8212). |
| Applications: | IP,IHC-Fr,Flow Cyt |
| Shipping condition: | Blue Ice |
| Publications: | Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.Whartenby KA, Calabresi PA, McCadden E, Nguyen B, Kardian D, Wang T, Mosse C, Pardoll DM, Small D. Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16741-6. Epub 2005 Nov 4. |